Product Liability

October 18, 2010

When Dangerous Drugs Happen to Good People: Drug Product Liability Attorney

We are the Fort Worth Texas Fosamax Product Liability Attorney Dr. Shezad Malik.

The FDA found that in some cases two types of drugs that were supposed to be preventing serious medical problems were, in fact, causing them.

Bisphosphonates like Fosamax, Actonel and Boniva, will now have to carry labels saying they can lead to rare fractures of the thigh bone, a discovery that came after another finding that they can cause a rare degeneration of the jawbone called osteonecrosis.

The other is Avandia, a blockbuster drug which was prescribed for diabetics. Diabetics are at high risk because of the disease process, for heart attacks and heart failure. Now the F.D.A. and drug regulators in Europe are restricting Avandia’s use because it appears to increase heart risks, according to research studies. Talk about a double whammy.

In both cases, the respective drug companies continue to deny any liability to the disease processes associated with the usage of their drugs.

Read Article: The New York Times

October 17, 2010

Medtronic to Pay $268 M to Settle Law Suits Over Defibrillator Wire Defects

by Dr. Shezad Malik

Medtronic said it is resolving claims that wires connecting implantable Sprint Fidelis defibrillators to patients’ hearts were defective. In 2009, the company estimated that at least 13 people may have died because of the problem.

Medtronic said it has agreed to pay $268 million to settle U.S. lawsuits and claims related to its Sprint Fidelis family of defibrillation leads which it recalled three years ago.

The settlement “will provide an average payout of more than $33,000 to patients who have defibrillators with wires that have broken or are considered likely to break.” Company officials estimate “that 170,000 people worldwide still have defibrillators with the Sprint Fidelis leads inside them.” Read full story Bloomberg News.

October 16, 2010

Yaz Lawsuit Update: Plaintiff Mini Trials to Start Fall 2011

by Dr. Shezad Malik

The first Yasmin and Yaz Product Liability Federal lawsuit trials are underway according to the recent MDL Southern District of Illinois Court Order. Our Fort Worth Yaz Injury Lawyer law firm is currently handling many cases in the Federal Yaz MDL which is consolidated in Southern District of Illinois, based in East St Louis.

These Federal MDL product liability cases involve allegations that women who took the oral contraceptive birth control pills suffered serious medical problems. 10% of the injury cases are strokes, 40% are venous thromboembolism (VTE), which include deep vein thrombosis (DVT) and pulmonary embolism (PE) and the remainder are gallbladder injuries.

Bell Weather Trial Case Selection and Process
In Complex Class action or MDL litigation, bell-weather trials allow the parties to evaluate how jurors respond to evidence that will be presented in the upcoming individual litigation.

The Court’s order calls for the parties to each choose 25 cases. All of the injury cases will be either gallbladder injuries or VTE. Yaz and Yasmin stroke lawsuits will not be part of the bell-weather trials because of their low percentage of personal injuries.

After case-specific discovery on the 50 chosen cases, the list of cases will be reduced to 24. The parties will select four PE cases, four gallbladder cases and four other VTE lawsuits. Each party will be allowed to veto one of the other side’s cases from each injury group. The Court will then choose one case from each group to serve as the bell-weather trial. The two other cases are backups in the event the first case cannot be tried for some reason.

The Yaz bell-weather trials will begin with a pulmonary embolism lawsuit on September 12, 2011, followed by a gallbladder injury lawsuit that has been set for trial January 9, 2012 and another VTE case that has been set for trial to begin April 2, 2012.

October 15, 2010

Dallas Fort Worth Texas DePuy Hip Implant Recall Lawyer

by Dr. Shezad Malik

Patients who received a DePuy ASR hip replacement made by a unit of Johnson and Johnson, face a high risk of hip failure or other complications due to problems with the design of the metal-on-metal hip implant.

DEPUY ASR LAWSUIT UPDATE: A recall for the hip implant was issued in August 2010, nearly a year-and-a-half after the first lawsuit over DePuy ASR hip problems was filed. The DePuy ASR Hip System is a metal-on-metal hip replacement device. Read the company’s information here for patients.

The DePuy ASR hip failure rate at five years is between 12% and 13% (one out of every 8 patients), and may be even higher among women and those who received a device with a smaller head (under 50mm).

DEPUY ASR HIP REPLACEMENT PROBLEMS: According to FDA Adverse Event Reports, more than 400 reports involving DePuy ASR hip problems have been received by the federal regulatory agency since the start of 2008.

The signs of a problem with the DePuy ASR Hip, are loosening of the hip implant, fracture of the bone around the implant, or dislocation of the two parts of the hip implant that move against each other.

Problems with metal-on-metal hip implants like the DePuy ASR have been associated with metal particles that could shed into the body as the hip implants wear down.The metallic debris could damage the tissue and bone surrounding the hip implant, potentially causing a loosening of the hip.

DEPUY ASR RECALL: On August 26, 2010, DePuy Orthopaedics announced the recall of DePuy ASR XL Acetabular Hip System and DePuy ASR Hip Resurfacing System implants, after confirming that they have an unreasonably high failure rate.

DePuy Orthopaedics did not acknowledge until March 2010 that there was a higher-than-expected failure rate with DePuy ASR hip implants, and did not recall DePuy ASR hip replacement implants until August 2010.

October 13, 2010

DePuy Hip Replacement Lawsuit – Hip Recall Lawyer

by Dr. Shezad Malik

As a Fort Worth Texas Depuy Hip Recall law firm, we have begun evaluating and accepting Depuy Hip Product Liability claims for patients nationwide who are affected by the Depuy hip recall. The DePuy ASR hip replacements have been found to fail at a high rate and this results in the patient needing to have the device removed and replaced in a revision surgery.

Our investigation of the DePuy ASR Hip has revealed that the device causes high levels of metal ion release into patients implanted with the device.

Patients who have had a hip replacement since 2003 and are experiencing pain are urged to contact their orthopedic surgeons or the hospital where their hip surgery took place to find out if the DePuy ASR Hip was used in their hip replacement surgery.

DePuy Orthopaedics, made a voluntary recall for their ASR XL Acetabular System which was sold in the U.S. The recall was promted by the discovery that 12-13% of patient’s metal-on-metal implants failed within just five years time, prompting a painful revision surgery.

DePuy sent a letter to orthopaedic hip surgeons to alert them of the recall and in addition, they provided an informational packet and medical release form to be passed out to patients.

We at the Dr Shezad Malik Law Firm strongly advise anyone with a DePuy hip to not sign that release. You do not want to give DePuy the right to review at all your confidential medical records and to take possession of the defective implant after revision surgery.

DePuy pays surgeons $50 for each medical release they convince their patients to sign. Depuy will use that medical information against the patient during litigation. The defective hip implant is the most critical piece of evidence that a patient has in their claim

October 12, 2010

Jury Verdict: Pfizer’s Wyeth Unit Properly Warned Woman’s Doctors On Prempro Risks.

by Dr. Shezad Malik

As a Fort Worth Defective Drug Product Liability Attorney I am providing this update regarding the status of class actions lawsuits involving Prempro.

According to Bloomberg News, “Pfizer Inc.’s Wyeth unit properly warned a Virginia woman’s doctors about the risks of its Prempro menopause drug, the jury ruled in rejecting her claim for damages.”

Jurors found that “Georgia Torkie-Tork couldn’t show that Wyeth officials downplayed the breast-cancer risks associated with Prempro, a hormone-replacement drug.

October 12, 2010

Dallas DePuy ASR Hip Replacement Attorney

by Dr. Shezad Malik

DePuy Orthopaedics, Inc.,a unit of Johnson and Johnson, recently announced the recall of its ASR Hip Replacement Systems. It is estimated that there are 93,000 implants worldwide. This recall came about as a result of a higher rate of failure requiring another hip replacement within 5 years.

If you have a DePuy ASR XL Acetabular or DePuy ASR Hip Resurfacing System should receive a letter informing you of the recall. The first step is to consult your doctor.

If you or a family member has been personally injured because of the fault of someone else: by the use of dangerous and defective drugs, bad products, or toxic injury etc then please contact the Dallas Fort Worth DePuy ASR Hip Replacement Product Liability Attorney Dr. Shezad Malik. For a no obligation, free case analysis, please call 214-390-3189 or Contact Me Online.

October 11, 2010

FDA Recalls Meridia Due To Heart Problems

by Dr. Shezad Malik

As a Fort Worth Product Liability attorney I read with interest this new FDA Meridia warning and recall.

The F.D.A. has announced a recall of the diet drug Meridia due to its link to increased risk of heart attacks and strokes.

Abbott Laboratories has agreed to voluntarily withdraw its obesity drug Meridia (sibutramine) from the U.S. market because of clinical trial data indicating an increased risk of heart attack and stroke, according to the U.S. Food and Drug Administration.

A recent study showed that people who take Meridia experience a 16 percent increase in the risk of serious heart problems, including non-fatal heart attacks, non-fatal strokes. Read Article: The Washington Post

October 10, 2010

Fort Worth DePuy ASR Class Action Lawsuits

by Dr. Shezad Malik

As a Fort Worth DePuy ASR class action attorney and law firm, we have been following closely the events surrounding the DePuy artificial hip replacement and the lawsuits that have followed.

The negligent actions by DePuy Orthopaedics have led to multiple DePuy ASR Class Action Lawsuits involving patients from the world. The main negligence allegations are that the company knew about the high failure rate of its hip devices for years before taking action to fix the device or remove it.

On August 19, 2010 the FDA sent a warning letter to the manufacturers of the DePuy ASR Hip Replacement, DePuy Orthopaedics, regarding other orthopedic devices.

Read here the DePuy Recall Guide for patients.

If you or a family member has been personally injured because of the fault of someone else: by the use of dangerous and defective drugs, bad products, or toxic injury etc then please contact the Fort Worth Texas DePuy ASR Hip Replacement Product Liability Attorney Dr. Shezad Malik. For a no obligation, free case analysis, please call 214-390-3189 or Contact Me Online.

The Dr. Shezad Malik Law Firm is currently evaluating and accepting DePuy ASR Hip Replacement cases.

October 9, 2010

Dallas Benzene Leukemia Attorney

by Dr. Shezad Malik

As a Dallas Benzene Leukemia Attorney I have followed the news surrounding the oil and gas extraction from the Barnett Shale.

The gas companies are releasing untold amounts of Benzene into the atmosphere and polluting the ground water.

Folks, wake up and smell the roses. We have only one Texas and one World. If you crap this up, we have no where to go. Raise your hands those of you who want to live in a sewer.

Benzene is a volatile hydrocarbon, a product from the Petroleum Industry.

Trouble is, Benzene it is a known carcinogen and very toxic. Many blood cancers occur as a result of exposure to this chemical.